open access

Vol 13, No 1 (2019)
Review paper
Published online: 2019-04-04
Get Citation

Selected aspects of nutrition in palliative care

Karolina Kuźbicka1, Iga Pawłowska1, Ivan Kocić1
·
Palliat Med Pract 2019;13(1):17-21.
Affiliations
  1. Department of Pharmacology, Medical University of Gdańsk, ul. M. Skłodowskiej-Curie 3a, 80-210 Gdańsk, Poland

open access

Vol 13, No 1 (2019)
Review paper
Published online: 2019-04-04

Abstract

Proper nutrition in palliative care is essential to achieve a good quality of life of patients and better treatment
results. The diet should include the proper amount of calories and nutrients such as proteins, omega 3 fatty
acids, dietary fibre, vitamin D and vitamin C. The meals must be balanced, tasty, diverse and appetizing.
In this paper, an example of one-day diet for adult palliative care patients is proposed.

Palliat Med Pract 2019; 13, 1: 17–21

Abstract

Proper nutrition in palliative care is essential to achieve a good quality of life of patients and better treatment
results. The diet should include the proper amount of calories and nutrients such as proteins, omega 3 fatty
acids, dietary fibre, vitamin D and vitamin C. The meals must be balanced, tasty, diverse and appetizing.
In this paper, an example of one-day diet for adult palliative care patients is proposed.

Palliat Med Pract 2019; 13, 1: 17–21

Get Citation

Keywords

anorexia, cachexia, diet, nutrition, palliative care, quality of life

About this article
Title

Selected aspects of nutrition in palliative care

Journal

Palliative Medicine in Practice

Issue

Vol 13, No 1 (2019)

Article type

Review paper

Pages

17-21

Published online

2019-04-04

Page views

690

Article views/downloads

1041

DOI

10.5603/PMPI.2019.0003

Bibliographic record

Palliat Med Pract 2019;13(1):17-21.

Keywords

anorexia
cachexia
diet
nutrition
palliative care
quality of life

Authors

Karolina Kuźbicka
Iga Pawłowska
Ivan Kocić

References (34)
  1. http://www.who.int/cancer/palliative/definition/en/. (5.12.2018).
  2. van Bokhorst-de van der Schueren MAE. Nutritional support strategies for malnourished cancer patients. Eur J Oncol Nurs. 2005; 9 Suppl 2: S74–S83.
  3. Ravasco P. Aspects of taste and compliance in patients with cancer. Eur J Oncol Nurs. 2005; 9 Suppl 2: S84–S91.
  4. Sadeghi M, Keshavarz-Fathi M, Baracos V, et al. Cancer cachexia: Diagnosis, assessment, and treatment. Crit Rev Oncol Hematol. 2018; 127: 91–104.
  5. Bovio G, Bettaglio R, Bonetti G, et al. Evaluation of nutritional status and dietary intake in patients with advanced cancer on palliative care. Minerva Gastroenterol Dietol. 2008; 54(3): 243–250.
  6. Gangadharan A, Choi SE, Hassan A, et al. Protein calorie malnutrition, nutritional intervention and personalized cancer care. Oncotarget. 2017; 8(14): 24009–24030.
  7. Seruga B, Zhang H, Bernstein LJ, et al. Cytokines and their relationship to the symptoms and outcome of cancer. Nat Rev Cancer. 2008; 8(11): 887–899.
  8. Drummond MJ, Rasmussen BB. Leucine-enriched nutrients and the regulation of mammalian target of rapamycin signalling and human skeletal muscle protein synthesis. Curr Opin Clin Nutr Metab Care. 2008; 11(3): 222–226.
  9. Miller PE, Van Elswyk M, Alexander DD. Long-chain omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and blood pressure: a meta-analysis of randomized controlled trials. Am J Hypertens. 2014; 27(7): 885–896.
  10. Hegarty B, Parker G. Fish oil as a management component for mood disorders - an evolving signal. Curr Opin Psychiatry. 2013; 26(1): 33–40.
  11. Gerster H. Can adults adequately convert alpha-linolenic acid (18:3n-3) to eicosapentaenoic acid (20:5n-3) and docosahexaenoic acid (22:6n-3)? Int J Vitam Nutr Res. 1998; 68(3): 159–173.
  12. DeFilippis AP, Sperling LS. Understanding omega-3's. Am Heart J. 2006; 151(3): 564–570.
  13. Colomer R, Moreno-Nogueira JM, García-Luna PP, et al. N-3 fatty acids, cancer and cachexia: a systematic review of the literature. Br J Nutr. 2007; 97(5): 823–831.
  14. Dreher ML, Davenport AJ. Hass avocado composition and potential health effects. Crit Rev Food Sci Nutr. 2013; 53(7): 738–750.
  15. Holick MF. Vitamin D deficiency. N Engl J Med. 2007; 357: 266–281.
  16. Hewison M. Antibacterial effects of vitamin D. Nat Rev Endocrinol. 2011; 7(6): 337–345.
  17. Wrzosek M, Jakubczyk A, Wrzosek M, et al. Vitamin D and the central nervous system. Pharmacol Rep. 2013; 65(2): 271–278.
  18. Dev R, Del Fabbro E, Schwartz GG, et al. Preliminary report: vitamin D deficiency in advanced cancer patients with symptoms of fatigue or anorexia. Oncologist. 2011; 16(11): 1637–1641.
  19. Bergman P, Sperneder S, Höijer J, et al. Low vitamin D levels are associated with higher opioid dose in palliative cancer patients--results from an observational study in Sweden. PLoS One. 2015; 10(5): e0128223.
  20. Helde-Frankling M, Höijer J, Bergqvist J, et al. Vitamin D supplementation to palliative cancer patients shows positive effects on pain and infections-Results from a matched case-control study. PLoS One. 2017; 12(8): e0184208.
  21. Sepehrmanesh Z, Kolahdooz F, Abedi F, et al. Vitamin D Supplementation Affects the Beck Depression Inventory, Insulin Resistance, and Biomarkers of Oxidative Stress in Patients with Major Depressive Disorder: A Randomized, Controlled Clinical Trial. J Nutr. 2016; 146(2): 243–248.
  22. Holick MF. Vitamin D deficiency. N Engl J Med. 2007; 357: 266–281.
  23. Englard S, Seifter S. The biochemical functions of ascorbic acid. Annu Rev Nutr. 1986; 6: 365–406.
  24. Carr AC, Frei B. Toward a new recommended dietary allowance for vitamin C based on antioxidant and health effects in humans. Am J Clin Nutr. 1999; 69(6): 1086–1107.
  25. Doll S, Ricou B. Severe vitamin C deficiency in a critically ill adult: a case report. Eur J Clin Nutr. 2013; 67(8): 881–882.
  26. Fukushima R, Yamazaki E. Vitamin C requirement in surgical patients. Curr Opin Clin Nutr Metab Care. 2010; 13(6): 669–676.
  27. Marcus SL, Dutcher JP, Paietta E, et al. Severe hypovitaminosis C occurring as the result of adoptive immunotherapy with high-dose interleukin 2 and lymphokine-activated killer cells. Cancer Res. 1987; 47(15): 4208–4212.
  28. Alexandrescu DT, Dasanu CA, Kauffman CL. Acute scurvy during treatment with interleukin-2. Clin Exp Dermatol. 2009; 34(7): 811–814.
  29. Oak ASW, Jaleel T, Fening K, et al. A case of scurvy associated with nilotinib. J Cutan Pathol. 2016; 43(8): 725–726.
  30. Günes-Bayir A, Kiziltan HS. Palliative Vitamin C Application in Patients with Radiotherapy-Resistant Bone Metastases: A Retrospective Study. Nutr Cancer. 2015; 67(6): 921–925.
  31. Yeom CH, Jung GC, Song KJ. Changes of terminal cancer patients' health-related quality of life after high dose vitamin C administration. J Korean Med Sci. 2007; 22(1): 7–11.
  32. Vollbracht C, Schneider B, Leendert V, et al. Intravenous vitamin C administration improves quality of life in breast cancer patients during chemo-/radiotherapy and aftercare: results of a retrospective, multicentre, epidemiological cohort study in Germany. In Vivo. 2011; 25(6): 983–990.
  33. Murata A, Morishige F, Yamaguchi H. Prolongation of survival times of terminal cancer patients by administration of large doses of ascorbate. Int J Vitam Nutr Res Suppl. 1982; 23: 103–113.
  34. Carr AC, Vissers MCM, Cook J. Parenteral vitamin C for palliative care of terminal cancer patients. N Z Med J. 2014; 127(1396): 84–86.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73 , 80–180 Gdańsk, Poland

phone:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl